{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:51:10Z","timestamp":1792511470075,"version":"4.5.0"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Private Universit\u00e4t Witten\/Herdecke gGmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Trauma Emerg Surg"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Our aim was to update the evidence-based and consensus-based recommendations for inhospital coagulation management and fluid replacement therapy in patients with multiple and\/or severe injuries on the basis of current evidence. This guideline topic is part of the 2022 update of the German Guideline on the Treatment of Patients with Multiple and\/or Severe Injuries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>MEDLINE and Embase were systematically searched to May 2021. Further literature reports were obtained from clinical experts. Randomised controlled trials, prospective cohort studies, and comparative registry studies were included if they compared interventions for the prevention of acidaemia, hypocalcaemia and hypothermia, for coagulation management, fluid replacement therapy, blood product transfusions, viscoelastic assays, or central venous access in patients with multiple and\/or severe injuries in the hospital setting. We considered patient-relevant clinical outcomes, such as mortality and bleeding control, or coagulation parameters as surrogate outcomes. Risk of bias was assessed using NICE 2012 checklists. The evidence was synthesised narratively, and expert consensus was used to develop recommendations and determine their strength.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fifty-nine new studies were identified. Interventions covered were blood products (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200919 studies), coagulation management (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200914), viscoelastic assays (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200912), temperature management (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20095), fluid replacement therapy (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20094), base excess\/lactate (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093), calcium (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091), and intravenous access (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091). Twelve recommendations were modified, and seven additional recommendations were developed. All achieved strong consensus.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The key recommendations are summarised as follows.<\/jats:p>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Trauma-induced coagulopathy (TIC) is a distinct clinical entity requiring early diagnostic and therapeutic interventions.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Perform viscoelastic assays in order to aid in the diagnosis and treatment of TIC in severely bleeding trauma patients.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Since only approximately 20% of trauma patients are hyperfibrinolytic and tranexamic acid is not beneficial in the absence of hyperfibrinolysis, TXA should not be indiscriminately used in all patients in the emergency department.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Coagulation factor concentrates as well as TXA are indicated in patients with life-threatening haemorrhage and\/or haemorrhagic shock.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00068-025-02919-2","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T10:28:14Z","timestamp":1751020094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Inhospital coagulation management and fluid replacement therapy in patients with multiple and\/or severe injuries \u2013 a systematic review and clinical practice guideline update"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7374-4324","authenticated-orcid":false,"given":"Heiko","family":"Lier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1436-1144","authenticated-orcid":false,"given":"K\u00e4the","family":"Goossen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4170-3290","authenticated-orcid":false,"given":"Charlotte M.","family":"Kugler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8113-0522","authenticated-orcid":false,"given":"Erwin","family":"Strasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8333-6367","authenticated-orcid":false,"given":"Bj\u00f6rn","family":"Hussmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0634-4723","authenticated-orcid":false,"given":"Marc","family":"Maegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4704-2377","authenticated-orcid":false,"given":"Peter","family":"Hilbert-Carius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"2919_CR1","unstructured":"S3-Leitlinie Polytrauma\/Schwerverletzten-Behandlung, Registernummer 187\u2013\u2009023. (2022), Version 4.1. https:\/\/www.awmf.org\/leitlinien\/detail\/ll\/187-023.html"},{"issue":"2","key":"2919_CR2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.7326\/M16-1565","volume":"166","author":"Y Chen","year":"2017","unstructured":"Chen Y, Yang K, Marusic A, Qaseem A, Meerpohl JJ, Flottorp S, et al. A reporting tool for practice guidelines in health care: the RIGHT statement. Ann Intern Med. 2017;166(2):128\u201332. https:\/\/doi.org\/10.7326\/M16-1565. Epub 20161122.","journal-title":"Ann Intern Med"},{"key":"2919_CR3","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"2919_CR4","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF)-St\u00e4ndige Kommission Leitlinien. AWMF-Regelwerk \u201eLeitlinien. 2nd Edition 2020. http:\/\/www.awmf.org\/leitlinien\/awmf-regelwerk.html. Accessed 11 November 2021."},{"key":"2919_CR5","unstructured":"Deutsche Gesellschaft f\u00fcr Unfallchirurgie e.V. (DGU). Leitlinienreport zur AWMF Leitlinie Polytrauma \/ Schwerverletzten-Behandlung, Registernummer 012\u2013019. (2016). https:\/\/register.awmf.org\/assets\/guidelines\/187_Orthop%C3%A4die_und_Unfallchirurgie\/012-019m_S3_Polytrauma_Schwerverletzten-Behandlung_2016-09-abgelaufen.pdf. Accessed 6 March 2023."},{"key":"2919_CR6","unstructured":"Gliklich R, Dreyer N, Leavy M, editors. Registries for Evaluating Patient Outcomes: A User\u2019s Guide. Third edition. Two volumes. AHRQ Publication No. 13(14)-EHC111. Rockville, MD: Agency for Healthcare Research and Quality; April 2014. http:\/\/www.effectivehealthcare.ahrq.gov\/registries-guide-3.cfm. Prepared by the Outcome DEcIDE Center [Outcome Sciences, Inc., a Quintiles company] under Contract No. 290 2005 00351 TO7."},{"issue":"1","key":"2919_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4. Epub 20161205.","journal-title":"Syst Rev"},{"key":"2919_CR8","unstructured":"National Institute for Health and Care Excellence (NICE). The guidelines manual: Appendices B-I, Published: 30 November 2012. Available from: https:\/\/www.nice.org.uk\/process\/pmg6\/resources\/the-guidelines-manual-appendices-bi-2549703709. Last accessed March 21, 2022."},{"key":"2919_CR9","unstructured":"OCEBM Levels of Evidence Working Group*. Oxford Centre for Evidence-based Medicine Levels of Evidence. (March 2009). Available from: https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009. Last accessed March 21, 2022. 2009."},{"issue":"4","key":"2919_CR10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the journal of clinical epidemiology. J Clin Epidemiol. 2011;64(4):380\u20132.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2919_CR11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00134-020-06266-1","volume":"47","author":"K Baksaas-Aasen","year":"2021","unstructured":"Baksaas-Aasen K, Gall LS, Stensballe J, Juffermans NP, Curry N, Maegele M, et al. Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial. Intensive Care Med. 2021;47(1):49\u201359.","journal-title":"Intensive Care Med"},{"issue":"6","key":"2919_CR12","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/SLA.0000000000001608","volume":"263","author":"E Gonzalez","year":"2016","unstructured":"Gonzalez E, Moore EE, Moore HB, Chapman MP, Chin TL, Ghasabyan A, et al. Goal-directed hemostatic resuscitation of Trauma-induced coagulopathy: A pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays. Ann Surg. 2016;263(6):1051\u20139.","journal-title":"Ann Surg"},{"issue":"6","key":"2919_CR13","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/TA.0000000000001044","volume":"80","author":"MM Carrick","year":"2016","unstructured":"Carrick MM, Morrison CA, Tapia NM, Leonard J, Suliburk JW, Norman MA, et al. Intraoperative hypotensive resuscitation for patients undergoing laparotomy or thoracotomy for trauma: early termination of a randomized prospective clinical trial. J Trauma Acute Care Surg. 2016;80(6):886\u201396.","journal-title":"J Trauma Acute Care Surg"},{"issue":"7","key":"2919_CR14","first-page":"5319","volume":"13","author":"X Gu","year":"2020","unstructured":"Gu X, Wang S, Chen J, Cao F, Zhou L. Restricted fluid resuscitation improves the prognosis of patients with traumatic hemorrhagic shock. Int J Clin Exp Med. 2020;13(7):5319\u201327.","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"2919_CR15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/SHK.0000000000000303","volume":"43","author":"J Han","year":"2015","unstructured":"Han J, Ren HQ, Zhao QB, Wu YL, Qiao ZY. Comparison of 3% and 7.5% hypertonic saline in resuscitation after traumatic hypovolemic shock. Shock. 2015;43(3):244\u20139.","journal-title":"Shock"},{"issue":"5","key":"2919_CR16","first-page":"1120","volume":"34","author":"Y Lu","year":"2018","unstructured":"Lu Y, Liu L, Wang J, Cui L. Controlled blood pressure elevation and limited fluiresuscitation in the treatment of multiple injuries in combination with shock. Pakistan J Med Sci. 2018;34(5):1120\u20134.","journal-title":"Pakistan J Med Sci"},{"issue":"21","key":"2919_CR17","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1001\/jama.2018.17075","volume":"320","author":"DJ Cooper","year":"2018","unstructured":"Cooper DJ, Nichol AD, Bailey M, Bernard S, Cameron PA, Pili-Floury S, et al. Effect of early sustained prophylactic hypothermia on neurologic outcomes among patients with severe traumatic brain injury: the POLAR randomized clinical trial. JAMA. 2018;320(21):2211\u201320.","journal-title":"JAMA."},{"issue":"1","key":"2919_CR18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13049-017-0465-y","volume":"25","author":"T Hifumi","year":"2017","unstructured":"Hifumi T, Kuroda Y, Kawakita K, Yamashita S, Oda Y, Dohi K, et al. Therapeutic hypothermia in patients with coagulopathy following severe traumatic brain injury. Scandinavian J Trauma Resusc Emerg Med. 2017;25(1):120.","journal-title":"Scandinavian J Trauma Resusc Emerg Med"},{"issue":"7","key":"2919_CR19","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1089\/neu.2013.3197","volume":"32","author":"T Maekawa","year":"2015","unstructured":"Maekawa T, Yamashita S, Nagao S, Hayashi N, Ohashi Y. Prolonged mild therapeutic hypothermia versus fever control with tight hemodynamic monitoring and slow rewarming in patients with severe traumatic brain injury: a randomized controlled trial. J Neurotrauma. 2015;32(7):422\u20139. https:\/\/doi.org\/10.1089\/neu.2013.3197.","journal-title":"J Neurotrauma"},{"issue":"4","key":"2919_CR20","first-page":"4056","volume":"11","author":"H Zhou","year":"2018","unstructured":"Zhou H, Zhang N, Zhou H, Jia Z. Influence of phased body temperature management for severe abdominal traumatic patients with hemorrhagic shock. Int J Clin Exp Med. 2018;11(4):4056\u201363.","journal-title":"Int J Clin Exp Med"},{"issue":"11","key":"2919_CR21","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.ajem.2018.02.018","volume":"36","author":"E Akbari","year":"2018","unstructured":"Akbari E, Safari S, Hatamabadi H. The effect of fibrinogen concentrate and fresh frozen plasma on the outcome of patients with acute traumatic coagulopathy: A quasi-experimental study. Am J Emerg Med. 2018;36(11):1947\u201350.","journal-title":"Am J Emerg Med"},{"issue":"6","key":"2919_CR22","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.1016\/S2352-3026(17)30077-7","volume":"4","author":"P Innerhofer","year":"2017","unstructured":"Innerhofer P, Fries D, Mittermayr M, Innerhofer N, von Langen D, Hell T, et al. Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial. Lancet Haematol. 2017;4(6):e258-71.","journal-title":"Lancet Haematol"},{"key":"2919_CR23","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.wneu.2019.09.024","volume":"132","author":"LM Zhang","year":"2019","unstructured":"Zhang LM, Li R, Sun WB, Wang XP, Qi MM, Bai Y, et al. Low-Dose, early fresh frozen plasma transfusion therapy after severe trauma brain injury: A clinical, prospective, randomized, controlled study. World Neurosurg. 2019;132:e21-7.","journal-title":"World Neurosurg"},{"issue":"10210","key":"2919_CR24","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(19)32233-0","volume":"394","author":"CRASH-3 trial collaborators","year":"2019","unstructured":"CRASH-3 trial collaborators. Effects of Tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet. 2019;394(10210):1713\u201323.","journal-title":"Lancet"},{"key":"2919_CR25","first-page":"05","volume":"5","author":"FX Guyette","year":"2020","unstructured":"Guyette FX, Brown JB, Zenati MS, Early-Young BJ, Adams PW, Eastridge BJ, et al. Tranexamic acid during prehospital transport in patients at risk for hemorrhage after injury: A Double-blind, Placebo-Controlled, randomized clinical trial. JAMA Surg. 2020;5:05.","journal-title":"JAMA Surg"},{"issue":"1","key":"2919_CR26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.annemergmed.2018.11.018","volume":"74","author":"DK Nishijima","year":"2019","unstructured":"Nishijima DK, Kuppermann N, Roberts I, VanBuren JM, Tancredi DJ. The effect of Tranexamic acid on functional outcomes: an exploratory analysis of the CRASH-2 randomized controlled trial. Ann Emerg Med. 2019;74(1):79\u201387.","journal-title":"Ann Emerg Med"},{"key":"2919_CR27","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.3389\/fimmu.2020.02085","volume":"11","author":"PC Spinella","year":"2020","unstructured":"Spinella PC, Thomas KA, Turnbull IR, Fuchs A, Bochicchio K, Schuerer D, et al. The Immunologic Effect of Early Intravenous Two and Four Gram Bolus Dosing of Tranexamic Acid Compared to Placebo in Patients With Severe Traumatic Bleeding (TAMPITI): A Randomized, Double-Blind, Placebo-Controlled\u00a0Single-Center Trial. Front Immunol. 2020;11:2085.","journal-title":"Front Immunol"},{"issue":"1","key":"2919_CR28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13054-018-2086-x","volume":"22","author":"N Curry","year":"2018","unstructured":"Curry N, Foley C, Wong H, Mora A, Curnow E, Zarankaite A, et al. Early fibrinogen concentrate therapy for major haemorrhage in trauma (E-FIT 1): results from a UK multi-centre, randomised, double blind, placebo-controlled pilot trial. Crit Care (London England). 2018;22(1):164.","journal-title":"Crit Care (London England)"},{"issue":"3","key":"2919_CR29","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/jth.13929","volume":"16","author":"D Garrigue","year":"2018","unstructured":"Garrigue D, Godier A, Glacet A, Labreuche J, Kipnis E, Paris C, et al. French lyophilized plasma versus fresh frozen plasma for the initial management of trauma-induced coagulopathy: a randomized open-label trial. J Thromb Haemostasis. 2018;16(3):481\u20139.","journal-title":"J Thromb Haemostasis"},{"issue":"6","key":"2919_CR30","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/bja\/aew343","volume":"117","author":"B Nascimento","year":"2016","unstructured":"Nascimento B, Callum J, Tien H, Peng H, Rizoli S, Karanicolas P, et al. Fibrinogen in the initial resuscitation of severe trauma (FiiRST): a randomized feasibility trial. Br J Anaesth. 2016;117(6):775\u201382.","journal-title":"Br J Anaesth"},{"issue":"5","key":"2919_CR31","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/TA.0000000000002614","volume":"88","author":"HB Moore","year":"2020","unstructured":"Moore HB, Tessmer MT, Moore EE, Sperry JL, Cohen MJ, Chapman MP, et al. Forgot calcium? Admission ionized-calcium in two civilian randomized controlled trials of prehospital plasma for traumatic hemorrhagic shock. J Trauma Acute Care Surg. 2020;88(5):588\u201396.","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"2919_CR32","doi-asserted-by":"crossref","first-page":"e195085","DOI":"10.1001\/jamasurg.2019.5085","volume":"155","author":"AE Pusateri","year":"2020","unstructured":"Pusateri AE, Moore EE, Moore HB, Le TD, Guyette FX, Chapman MP, et al. Association of prehospital plasma transfusion with survival in trauma patients with hemorrhagic shock when transport times are longer than 20 minutes: A post hoc analysis of the pamper and COMBAT clinical trials. JAMA Surg. 2020;155(2):e195085.","journal-title":"JAMA Surg"},{"issue":"1","key":"2919_CR33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/TA.0000000000002485","volume":"88","author":"KM Reitz","year":"2020","unstructured":"Reitz KM, Moore HB, Guyette FX, Sauaia A, Pusateri AE, Moore EE, et al. Prehospital plasma in injured patients is associated with survival principally in blunt injury: results from two randomized prehospital plasma trials. J Trauma Acute Care Surg. 2020;88(1):33\u201341.","journal-title":"J Trauma Acute Care Surg"},{"issue":"5","key":"2919_CR34","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/TA.0000000000002022","volume":"85","author":"M Khan","year":"2018","unstructured":"Khan M, Jehan F, Bulger EM, O\u2019Keeffe T, Holcomb JB, Wade CE, et al. Severely injured trauma patients with admission hyperfibrinolysis: is there a role of Tranexamic acid? Findings from the PROPPR trial. J Trauma Acute Care Surg. 2018;85(5):851\u20137.","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"2919_CR35","first-page":"48","volume":"18","author":"I Roberts","year":"2017","unstructured":"Roberts I, Edwards P, Prieto D, Joshi M, Mahmood A, Ker K, et al. Tranexamic acid in bleeding trauma patients: an exploration of benefits and harms. Trials [Electronic Resource]. 2017;18(1):48.","journal-title":"Trials [Electronic Resource]"},{"issue":"6","key":"2919_CR36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1186\/s13054-014-0685-8","volume":"18","author":"I Roberts","year":"2014","unstructured":"Roberts I, Prieto-Merino D, Manno D. Mechanism of action of Tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trial. Crit Care (London England). 2014;18(6):685.","journal-title":"Crit Care (London England)"},{"issue":"1","key":"2919_CR37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/ther.2020.0025","volume":"11","author":"EJ Quine","year":"2021","unstructured":"Quine EJ, Murray L, Trapani T, Cooper DJ. Thromboelastography to assess coagulopathy in traumatic brain injury patients undergoing therapeutic hypothermia. Therapeutic Hypothermia Temp Manage. 2021;11(1):53\u20137.","journal-title":"Therapeutic Hypothermia Temp Manage"},{"issue":"4","key":"2919_CR38","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00068-015-0573-1","volume":"42","author":"E Bui","year":"2016","unstructured":"Bui E, Inaba K, Ebadat A, Karamanos E, Byerly S, Okoye O, et al. The impact of increased plasma ratios in massively transfused trauma patients: a prospective analysis. Eur J Trauma Emerg Surg. 2016;42(4):519\u201325.","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"6","key":"2919_CR39","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/SLA.0000000000000366","volume":"260","author":"ME Kutcher","year":"2014","unstructured":"Kutcher ME, Kornblith LZ, Vilardi RF, Redick BJ, Nelson MF, Cohen MJ. The natural history and effect of resuscitation ratio on coagulation after trauma: a prospective cohort study. Ann Surg. 2014;260(6):1103\u201311.","journal-title":"Ann Surg"},{"key":"2919_CR40","first-page":"S2","volume":"60","author":"SM Shea","year":"2020","unstructured":"Shea SM, Staudt AM, Thomas KA, Schuerer D, Mielke JE, Folkerts D, et al. The use of low-titer group O whole blood is independently associated with improved survival compared to component therapy in adults with severe traumatic hemorrhage. Transfusion. 2020;60:S2-9.","journal-title":"Transfusion"},{"issue":"4","key":"2919_CR41","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/bjs.10052","volume":"103","author":"SJ Stanworth","year":"2016","unstructured":"Stanworth SJ, Davenport R, Curry N, Seeney F, Eaglestone S, Edwards A, et al. Mortality from trauma haemorrhage and opportunities for improvement in transfusion practice. Br J Surg. 2016;103(4):357\u201365.","journal-title":"Br J Surg"},{"key":"2919_CR42","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jss.2017.04.028","volume":"220","author":"HB Moore","year":"2017","unstructured":"Moore HB, Moore EE, Huebner BR, Stettler GR, Nunns GR, Einersen PM, et al. Tranexamic acid is associated with increased mortality in patients with physiological fibrinolysis. J Surg Res. 2017;220:438\u201343.","journal-title":"J Surg Res"},{"issue":"4","key":"2919_CR43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/JMU.JMU_2_19","volume":"27","author":"M Kunhahamed","year":"2019","unstructured":"Kunhahamed M, Abraham S, Palatty B, Krishnan S, Rajeev P, Gopinathan V. A comparison of internal jugular vein cannulation by ultrasound-guided and anatomical landmark technique in resource-limited emergency department setting. J Med Ultrasound. 2019;27(4):187\u201391.","journal-title":"J Med Ultrasound"},{"key":"2919_CR44","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jss.2020.08.077","volume":"258","author":"M Schellenberg","year":"2021","unstructured":"Schellenberg M, Benjamin E, Inaba K, Heindel P, Biswas S, Mooney JL, et al. When is it safe to start Pharmacologic venous thromboembolism prophylaxis after pelvic fractures?? A prospective study from a level I trauma center. J Surg Res. 2021;258:272\u20137.","journal-title":"J Surg Res"},{"issue":"11","key":"2919_CR45","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1007\/s00268-019-05096-7","volume":"43","author":"M Schellenberg","year":"2019","unstructured":"Schellenberg M, Inaba K, Biswas S, Heindel P, Benjamin E, Strumwasser A, et al. When is it safe to start VTE prophylaxis after blunt solid organ injury?? A prospective study from a level I trauma center. World J Surg. 2019;43(11):2797\u2013803.","journal-title":"World J Surg"},{"key":"2919_CR46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cca.2019.04.066","volume":"495","author":"HT Peng","year":"2019","unstructured":"Peng HT, Nascimento B, Tien H, Callum J, Rizoli S, Rhind SG, et al. A comparative study of viscoelastic hemostatic assays and conventional coagulation tests in trauma patients receiving fibrinogen concentrate. Clin Chim Acta. 2019;495:253\u201362.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"2919_CR47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.7205\/MILMED-D-15-00166","volume":"181","author":"S Rizoli","year":"2016","unstructured":"Rizoli S, Min A, Sanchez AP, Shek P, Grodecki R, Veigas P, et al. In trauma, conventional ROTEM and TEG results are not interchangeable but are similar in clinical applicability. Mil Med. 2016;181(5):117\u201326.","journal-title":"Mil Med"},{"key":"2919_CR48","doi-asserted-by":"crossref","unstructured":"Spagnolello O, Reed J, Dauncey M, Timony-Nolan S, Innes E, Allen C et al. JMM,. Introduction of a ROTEM protocol for the management of trauma-induced coagulopathy. Trauma (United Kingdom). 2020.","DOI":"10.1177\/1460408620957919"},{"issue":"2","key":"2919_CR49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12288-018-1003-4","volume":"35","author":"V Albert","year":"2019","unstructured":"Albert V, Subramanian A, Pati HP, Agrawal D, Bhoi SK. Efficacy of thromboelastography (TEG) in predicting acute Trauma-Induced coagulopathy (ATIC) in isolated severe traumatic brain injury (iSTBI). Indian J Hematol Blood Transfus. 2019;35(2):325\u201331.","journal-title":"Indian J Hematol Blood Transfus"},{"key":"2919_CR50","doi-asserted-by":"crossref","unstructured":"Balendran CA, Lovgren A, Hansson KM, Nel K, Olsson M et al. Prothrombin time is predictive of low plasma prothrombin concentration and clinical outcome in patients with trauma hemorrhage: analyses of prospective observational cohort studies. Scandinavian Journal of Trauma, Resuscitation & Emergency Medicine. 2017;25(1):30.","DOI":"10.1186\/s13049-016-0332-2"},{"issue":"6","key":"2919_CR51","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/TA.0000000000002941","volume":"89","author":"CD Barrett","year":"2020","unstructured":"Barrett CD, Moore HB, Vigneshwar N, Dhara S, Ch, ler J, et al. Plasmin thrombelastography rapidly identifies trauma patients at risk for massive transfusion, mortality, and hyperfibrinolysis: A diagnostic tool to resolve an international debate on Tranexamic acid? J Trauma Acute Care Surg. 2020;89(6):991\u20138.","journal-title":"J Trauma Acute Care Surg"},{"key":"2919_CR52","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/trf.15176","volume":"59","author":"J Cohen","year":"2019","unstructured":"Cohen J, Scorer T, Wright Z, Stewart IJ, Sosnov J, Pidcoke H, et al. A prospective evaluation of thromboelastometry (ROTEM) to identify acute traumatic coagulopathy and predict massive transfusion in military trauma patients in Afghanistan. Transfusion. 2019;59:1601\u20137.","journal-title":"Transfusion"},{"key":"2919_CR53","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jss.2017.01.008","volume":"212","author":"CR Connelly","year":"2017","unstructured":"Connelly CR, Yonge JD, McCully SP, Hart KD, Hilliard TC, Lape DE, et al. Assessment of three point-of-care platelet function assays in adult trauma patients. J Surg Res. 2017;212:260\u20139.","journal-title":"J Surg Res"},{"issue":"6","key":"2919_CR54","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/TA.0000000000001656","volume":"83","author":"SC Fligor","year":"2017","unstructured":"Fligor SC, Love KM, Collier BR, Lollar DI, Hamill ME, Benson AD, et al. Parathyroid hormone as a marker for hypoperfusion in trauma: A prospective observational study. J Trauma Acute Care Surg. 2017;83(6):1142\u20137.","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"2919_CR55","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jss.2016.06.103","volume":"205","author":"SC Gale","year":"2016","unstructured":"Gale SC, Kocik JF, Creath R, Crystal JS, Dombrovskiy VY. A comparison of initial lactate and initial base deficit as predictors of mortality after severe blunt trauma. J Surg Res. 2016;205(2):446\u201355.","journal-title":"J Surg Res"},{"key":"2919_CR56","doi-asserted-by":"crossref","unstructured":"Hagemo JS, Christiaans SC, Stanworth SJ, Brohi K, Johansson PI, Goslings JC, et al. Detection of acute traumatic coagulopathy and massive transfusion requirements by means of rotational thromboelastometry: an international prospective validation study. Crit Care (London England). 2015;19.","DOI":"10.1186\/s13054-015-0823-y"},{"issue":"9","key":"2919_CR57","doi-asserted-by":"crossref","first-page":"e889","DOI":"10.1097\/CCM.0000000000003275","volume":"46","author":"SD Hutchings","year":"2018","unstructured":"Hutchings SD, Naumann DN, Hopkins P, Mellis C, Riozzi P, Sartini S, et al. Microcirculatory impairment is associated with multiple organ dysfunction following traumatic hemorrhagic shock: the MICROSHOCK study. Crit Care Med. 2018;46(9):e889-96.","journal-title":"Crit Care Med"},{"issue":"1","key":"2919_CR58","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jamcollsurg.2017.02.018","volume":"225","author":"HB Moore","year":"2017","unstructured":"Moore HB, Moore EE, Chapman MP, Huebner BR, Einersen PM, Oushy S, et al. Viscoelastic tissue plasminogen activator challenge predicts massive transfusion in 15 minutes. J Am Coll Surg. 2017;225(1):138\u201347.","journal-title":"J Am Coll Surg"},{"issue":"14","key":"2919_CR59","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1182\/bloodadvances.2018017699","volume":"2","author":"JC Cardenas","year":"2018","unstructured":"Cardenas JC, Zhang X, Fox EE, Cotton BA, Hess JR, Schreiber MA, et al. Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial. Blood Adv. 2018;2(14):1696\u2013704.","journal-title":"Blood Adv"},{"key":"2919_CR60","first-page":"17","volume":"17","author":"M Chehab","year":"2021","unstructured":"Chehab M, Ditillo M, Obaid O, Nelson A, Poppe B, Douglas M, et al. Never-Frozen liquid plasma transfusion in civilian trauma: A nationwide Propensity-Matched analysis. J Trauma Acute Care Surg. 2021;17:17.","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"2919_CR61","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/TA.0000000000002903","volume":"89","author":"A de Roulet","year":"2020","unstructured":"de Roulet A, Kerby JD, Weinberg JA, Lewis RH Jr, Hudgins JP, Shulman IA, et al. Group A emergency-release plasma in trauma patients requiring massive transfusion. J Trauma Acute Care Surg. 2020;89(6):1061\u20137.","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"2919_CR62","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.hrtlng.2016.12.002","volume":"46","author":"AR Jones","year":"2017","unstructured":"Jones AR, Bush HM, Frazier SK. Injury severity, sex, and transfusion volume, but not transfusion ratio, predict inflammatory complications after traumatic injury. Heart Lung. 2017;46(2):114\u20139.","journal-title":"Heart Lung"},{"issue":"1","key":"2919_CR63","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/JTN.0000000000000025","volume":"21","author":"AR Jones","year":"2014","unstructured":"Jones AR, Frazier SK. Increased mortality in adult patients with trauma transfused with blood components compared with whole blood. J Trauma Nurs. 2014;21(1):22\u20139.","journal-title":"J Trauma Nurs"},{"issue":"6","key":"2919_CR64","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jamcollsurg.2019.10.012","volume":"230","author":"CJ Nederpelt","year":"2020","unstructured":"Nederpelt CJ, El Hechi MW, Kongkaewpaisan N, Kokoroskos N, Mendoza AE, Saillant NN, et al. Fresh frozen Plasma-to-Packed red blood cell ratio and mortality in traumatic hemorrhage: nationwide analysis of 4,427 patients. J Am Coll Surg. 2020;230(6):893\u2013901.","journal-title":"J Am Coll Surg"},{"key":"2919_CR65","doi-asserted-by":"crossref","unstructured":"Roquet F, Neuschw A, Hamada S, Fave G, Follin A et al. Association of Early, High Plasma-to-Red Blood Cell Transfusion Ratio With Mortality in Adults With Severe Bleeding After Trauma. JAMA Network Open. 2019;2(9):e1912076","DOI":"10.1001\/jamanetworkopen.2019.12076"},{"issue":"1","key":"2919_CR66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/TA.0000000000001532","volume":"83","author":"WT Stevens","year":"2017","unstructured":"Stevens WT, Morse BC, Bernard A, Davenport DL, Sams VG, Goodman MD, et al. Incompatible type A plasma transfusion in patients requiring massive transfusion protocol: outcomes of an Eastern association for the surgery of trauma multicenter study. J Trauma Acute Care Surg. 2017;83(1):25\u20139.","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"2919_CR67","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/TA.0000000000002262","volume":"87","author":"M Zeeshan","year":"2019","unstructured":"Zeeshan M, Hamidi M, Feinstein AJ, Gries L, Jehan F, Sakran J, et al. Four-factor prothrombin complex concentrate is associated with improved survival in trauma-related hemorrhage: A nationwide propensity-matched analysis. J Trauma Acute Care Surg. 2019;87(2):274\u201381.","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"2919_CR68","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/cts.12206","volume":"8","author":"MD Zielinski","year":"2015","unstructured":"Zielinski MD, Schrager JJ, Johnson P, Stubbs JR, Polites S, Zietlow SP, et al. Multicenter comparison of emergency release group A versus AB plasma in blunt-injured trauma patients. Clin Transl Sci. 2015;8(1):43\u20137.","journal-title":"Clin Transl Sci"},{"issue":"4","key":"2919_CR69","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jamcollsurg.2016.06.382","volume":"223","author":"JP Byrne","year":"2016","unstructured":"Byrne JP, Mason SA, Gomez D, Hoeft C, Subacius H, Xiong W, et al. Timing of Pharmacologic venous thromboembolism prophylaxis in severe traumatic brain injury: A Propensity-Matched cohort study. J Am Coll Surg. 2016;223(4):621\u201331..e5.\u00a0https:\/\/doi.org\/10.1016\/j.jamcollsurg.2016.06.382","journal-title":"J Am Coll Surg"},{"issue":"4","key":"2919_CR70","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1097\/ta.0000000000000095","volume":"76","author":"SN Acker","year":"2014","unstructured":"Acker SN, Partrick DA, Ross JT, Nadlonek NA, Bronsert M, Bensard DD. Blood component transfusion increases the risk of death in children with traumatic brain injury. J Trauma Acute Care Surg. 2014;76(4):1082\u20137. https:\/\/doi.org\/10.1097\/ta.0000000000000095.","journal-title":"J Trauma Acute Care Surg."},{"issue":"Suppl 5","key":"2919_CR71","doi-asserted-by":"publisher","first-page":"240s","DOI":"10.1111\/j.1537-2995.2008.01987.x","volume":"49","author":"KD Boffard","year":"2009","unstructured":"Boffard KD, Choong PI, Kluger Y, Riou B, Rizoli SB, Rossaint R, et al. The treatment of bleeding is to stop the bleeding!\u00a0Treatment of trauma-related hemorrhage. Transfusion. 2009;49(Suppl 5):240s\u20137s. https:\/\/doi.org\/10.1111\/j.1537-2995.2008.01987.x.","journal-title":"Transfusion"},{"issue":"5","key":"2919_CR72","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/SLA.0000000000000674","volume":"261","author":"JB Brown","year":"2015","unstructured":"Brown JB, Cohen MJ, Minei JP, Maier RV, West MA, Billiar TR, et al. Pretrauma center red blood cell transfusion is associated with reduced mortality and coagulopathy in severely injured patients with blunt trauma. Ann Surg. 2015;261(5):997\u20131005.","journal-title":"Ann Surg"},{"issue":"2","key":"2919_CR73","doi-asserted-by":"publisher","first-page":"R92","DOI":"10.1186\/cc10096","volume":"15","author":"N Curry","year":"2011","unstructured":"Curry N, Hopewell S, Doree C, Hyde C, Brohi K, Stanworth S. The acute management of trauma hemorrhage: a systematic review of randomized controlled trials. Crit Care. 2011;15(2):R92. https:\/\/doi.org\/10.1186\/cc10096.","journal-title":"Crit Care"},{"issue":"3","key":"2919_CR74","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/TA.0b013e3181edf36e","volume":"69","author":"CJ Hauser","year":"2010","unstructured":"Hauser CJ, Boffard K, Dutton R, Bernard GR, Croce MA, Holcomb JB, et al. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma. 2010;69(3):489\u2013500. https:\/\/doi.org\/10.1097\/TA.0b013e3181edf36e.","journal-title":"J Trauma."},{"issue":"5","key":"2919_CR75","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jama.2015.12","volume":"313","author":"JB Holcomb","year":"2015","unstructured":"Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313(5):471\u201382.","journal-title":"JAMA"},{"issue":"2","key":"2919_CR76","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.injury.2012.08.047","volume":"44","author":"P Innerhofer","year":"2013","unstructured":"Innerhofer P, Westermann I, Tauber H, Breitkopf R, Fries D, Kastenberger T, et al. The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. Injury. 2013;44(2):209\u201316. https:\/\/doi.org\/10.1016\/j.injury.2012.08.047.","journal-title":"Injury"},{"issue":"1","key":"2919_CR77","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.injury.2011.10.011","volume":"43","author":"B Mitra","year":"2012","unstructured":"Mitra B, Cameron PA, Gruen RL. Aggressive fresh frozen plasma (FFP) with massive blood transfusion in the absence of acute traumatic coagulopathy. Injury. 2012;43(1):33\u20137. https:\/\/doi.org\/10.1016\/j.injury.2011.10.011.","journal-title":"Injury"},{"issue":"4","key":"2919_CR78","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1742-6723.2012.01556.x","volume":"24","author":"B Mitra","year":"2012","unstructured":"Mitra B, O\u2019Reilly G, Collecutt M, Cameron PA, Phillips L, Davis A. Prospective comparison of point-of-care international normalised ratio measurement versus plasma international normalised ratio for acute traumatic coagulopathy. Emerg Med Australas. 2012;24(4):363\u20138.","journal-title":"Emerg Med Australas"},{"issue":"9","key":"2919_CR79","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.injury.2014.01.016","volume":"45","author":"B Mitra","year":"2014","unstructured":"Mitra B, Olaussen A, Cameron PA, O\u2019Donohoe T, Fitzgerald M. Massive blood transfusions post trauma in the elderly compared to younger patients. Injury. 2014;45(9):1296\u2013300. https:\/\/doi.org\/10.1016\/j.injury.2014.01.016.","journal-title":"Injury"},{"issue":"3","key":"2919_CR80","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/TA.0b013e31820e77ea","volume":"70","author":"CA Morrison","year":"2011","unstructured":"Morrison CA, Carrick MM, Norman MA, Scott BG, Welsh FJ, Tsai P, et al. Hypotensive resuscitation strategy reduces transfusion requirements and severe postoperative coagulopathy in trauma patients with hemorrhagic shock: preliminary results of a randomized controlled trial. J Trauma. 2011;70(3):652\u201363. https:\/\/doi.org\/10.1097\/TA.0b013e31820e77ea.","journal-title":"J Trauma."},{"issue":"3","key":"2919_CR81","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1001\/jamasurg.2013.764","volume":"148","author":"JJ Morrison","year":"2013","unstructured":"Morrison JJ, Ross JD, Dubose JJ, Jansen JO, Midwinter MJ, Rasmussen TE. Association of cryoprecipitate and Tranexamic acid with improved survival following wartime injury: findings from the matters II study. JAMA Surg. 2013;148(3):218\u201325. https:\/\/doi.org\/10.1001\/jamasurg.2013.764.","journal-title":"JAMA Surg"},{"issue":"8","key":"2919_CR82","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1177\/000313481107700825","volume":"77","author":"BC Morse","year":"2011","unstructured":"Morse BC, Dente CJ, Hodgman EI, Shaz BH, Nicholas JM, Wyrzykowski AD, et al. The effects of protocolized use of Recombinant factor VIIa within a massive transfusion protocol in a civilian level I trauma center. Am Surg. 2011;77(8):1043\u20139.","journal-title":"Am Surg"},{"issue":"12","key":"2919_CR83","doi-asserted-by":"publisher","first-page":"E583","DOI":"10.1503\/cmaj.121986","volume":"185","author":"B Nascimento","year":"2013","unstructured":"Nascimento B, Callum J, Tien H, Rubenfeld G, Pinto R, Lin Y, et al. Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomized feasibility trial. CMAJ. 2013;185(12):E583-9. https:\/\/doi.org\/10.1503\/cmaj.121986.","journal-title":"CMAJ"},{"issue":"7","key":"2919_CR84","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.injury.2010.12.015","volume":"42","author":"U Nienaber","year":"2011","unstructured":"Nienaber U, Innerhofer P, Westermann I, Schochl H, Attal R, Breitkopf R, et al. The impact of fresh frozen plasma vs coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion. Injury. 2011;42(7):697\u2013701.","journal-title":"Injury"},{"issue":"10","key":"2919_CR85","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.injury.2014.05.015","volume":"45","author":"SV Patel","year":"2014","unstructured":"Patel SV, Kidane B, Klingel M, Parry N. Risks associated with red blood cell transfusion in the trauma population, a meta-analysis. Injury. 2014;45(10):1522\u201333. https:\/\/doi.org\/10.1016\/j.injury.2014.05.015.","journal-title":"Injury"},{"issue":"1","key":"2919_CR86","doi-asserted-by":"publisher","first-page":"R68","DOI":"10.1186\/cc10048","volume":"15","author":"S Peiniger","year":"2011","unstructured":"Peiniger S, Nienaber U, Lefering R, Braun M, Wafaisade A, Wutzler S, et al. Balanced massive transfusion ratios in multiple injury patients with traumatic brain injury. Crit Care. 2011;15(1):R68. https:\/\/doi.org\/10.1186\/cc10048.","journal-title":"Crit Care"},{"issue":"6","key":"2919_CR87","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1097\/CCM.0b013e31820eb517","volume":"39","author":"A Rajasekhar","year":"2011","unstructured":"Rajasekhar A, Gowing R, Zarychanski R, Arnold DM, Lim W, Crowther MA, et al. Survival of trauma patients after massive red blood cell transfusion using a high or low red blood cell to plasma transfusion ratio. Crit Care Med. 2011;39(6):1507\u201313. https:\/\/doi.org\/10.1097\/CCM.0b013e31820eb517.","journal-title":"Crit Care Med"},{"issue":"4","key":"2919_CR88","doi-asserted-by":"publisher","first-page":"R147","DOI":"10.1186\/cc13982","volume":"18","author":"H Schochl","year":"2014","unstructured":"Schochl H, Voelckel W, Maegele M, Kirchmair L, Schlimp CJ. Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients. Crit Care. 2014;18(4):R147. https:\/\/doi.org\/10.1186\/cc13982.","journal-title":"Crit Care"},{"issue":"6","key":"2919_CR89","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1097\/ta.0000000000000242","volume":"76","author":"EJ Valle","year":"2014","unstructured":"Valle EJ, Allen CJ, Van Haren RM, Jouria JM, Li H, Livingstone AS, et al. Do all trauma patients benefit from Tranexamic acid? J Trauma Acute Care Surg. 2014;76(6):1373\u20138. https:\/\/doi.org\/10.1097\/ta.0000000000000242.","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"2919_CR90","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/TA.0b013e31827e2410","volume":"74","author":"A Wafaisade","year":"2013","unstructured":"Wafaisade A, Lefering R, Maegele M, Brockamp T, Mutschler M, Lendemans S, et al. Administration of fibrinogen concentrate in exsanguinating trauma patients is associated with improved survival at 6 hours but not at discharge. J Trauma Acute Care Surg. 2013;74(2):387\u20133. https:\/\/doi.org\/10.1097\/TA.0b013e31827e2410.","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"2919_CR91","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s00113-011-2146-z","volume":"116","author":"A Wafaisade","year":"2013","unstructured":"Wafaisade A, Lefering R, Maegele M, Helm P, Braun M, Paffrath T, et al. Recombinant factor VIIa for the treatment of exsanguinating trauma patients: a matched-pair analysis from the Trauma Registry of the German Society for Trauma Surgery. Unfallchirurg. 2013;116(6):524\u201330. https:\/\/doi.org\/10.1007\/s00113-011-2146-z.","journal-title":"Unfallchirurg"},{"issue":"5","key":"2919_CR92","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1553-2712.2009.00386.x","volume":"16","author":"S Zehtabchi","year":"2009","unstructured":"Zehtabchi S, Nishijima DK. Impact of transfusion of fresh-frozen plasma and packed red blood cells in a 1:1 ratio on survival of emergency department patients with severe trauma. Acad Emerg Med. 2009;16(5):371\u20138. https:\/\/doi.org\/10.1111\/j.1553-2712.2009.00386.x.","journal-title":"Acad Emerg Med"},{"issue":"7632","key":"2919_CR93","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1136\/bmj.39398.682500.25","volume":"335","author":"A Afshari","year":"2007","unstructured":"Afshari A, Wetterslev J, Brok J, Moller A. Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis. BMJ. 2007;335(7632):1248\u201351. https:\/\/doi.org\/10.1136\/bmj.39398.682500.25.","journal-title":"BMJ."},{"issue":"17","key":"2919_CR94","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1056\/nejm199410273311701","volume":"331","author":"WH Bickell","year":"1994","unstructured":"Bickell WH, Wall MJ Jr, Pepe PE, Martin RR, Ginger VF, Allen MK, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med. 1994;331(17):1105\u20139. https:\/\/doi.org\/10.1056\/nejm199410273311701.","journal-title":"N Engl J Med"},{"issue":"1","key":"2919_CR95","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/01.ta.0000171453.37949.b7","volume":"59","author":"KD Boffard","year":"2005","unstructured":"Boffard KD, Riou B, Warren B, Choong PI, Rizoli S, Rossaint R, et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma. 2005;59(1):8\u201315. https:\/\/doi.org\/10.1097\/01.ta.0000171453.37949.b7. discussion\u2013\u20098.","journal-title":"J Trauma"},{"issue":"4","key":"2919_CR96","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1097\/TA.0b013e3181271ba3","volume":"63","author":"MA Borgman","year":"2007","unstructured":"Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma. 2007;63(4):805\u201313. https:\/\/doi.org\/10.1097\/TA.0b013e3181271ba3.","journal-title":"J Trauma"},{"issue":"5","key":"2919_CR97","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1097\/TA.0b013e318169cd3c","volume":"64","author":"K Brohi","year":"2008","unstructured":"Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, Mackersie RC, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma. 2008;64(5):1211\u20137; discussion 7. https:\/\/doi.org\/10.1097\/TA.0b013e318169cd3c.","journal-title":"J Trauma."},{"issue":"2","key":"2919_CR98","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/ALN.0b013e3181948a97","volume":"110","author":"O Chaiwat","year":"2009","unstructured":"Chaiwat O, Lang JD, Vavilala MS, Wang J, MacKenzie EJ, Jurkovich GJ, et al. Early packed red blood cell transfusion and acute respiratory distress syndrome after trauma. Anesthesiology. 2009;110(2):351\u201360. https:\/\/doi.org\/10.1097\/ALN.0b013e3181948a97.","journal-title":"Anesthesiology."},{"key":"2919_CR99","doi-asserted-by":"publisher","unstructured":"Coats T, Roberts I, Shakur H. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev. 2004;(4):Cd004896. https:\/\/doi.org\/10.1002\/14651858.CD004896.pub2.\u00a0","DOI":"10.1002\/14651858.CD004896.pub2"},{"issue":"11","key":"2919_CR100","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1097\/01.ccm.0000186745.53059.f0","volume":"33","author":"SI Dara","year":"2005","unstructured":"Dara SI, Rana R, Afessa B, Moore SB, Gajic O. Fresh frozen plasma transfusion in critically ill medical patients with coagulopathy. Crit Care Med. 2005;33(11):2667\u201371. https:\/\/doi.org\/10.1097\/01.ccm.0000186745.53059.f0.","journal-title":"Crit Care Med"},{"issue":"6","key":"2919_CR101","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1097\/TA.0b013e3181a59ad5","volume":"66","author":"CJ Dente","year":"2009","unstructured":"Dente CJ, Shaz BH, Nicholas JM, Harris RS, Wyrzykowski AD, Patel S, et al. Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center. J Trauma. 2009;66(6):1616\u201324. https:\/\/doi.org\/10.1097\/TA.0b013e3181a59ad5.","journal-title":"J Trauma"},{"issue":"6","key":"2919_CR102","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1097\/00005373-200206000-00020","volume":"52","author":"RP Dutton","year":"2002","unstructured":"Dutton RP, Mackenzie CF, Scalea TM. Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma. 2002;52(6):1141\u20136. https:\/\/doi.org\/10.1097\/00005373-200206000-00020.","journal-title":"J Trauma"},{"issue":"2","key":"2919_CR103","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.clineuro.2006.09.001","volume":"109","author":"H Etemadrezaie","year":"2007","unstructured":"Etemadrezaie H, Baharvahdat H, Shariati Z, Lari SM, Shakeri MT, Ganjeifar B. The effect of fresh frozen plasma in severe closed head injury. Clin Neurol Neurosurg. 2007;109(2):166\u201371. https:\/\/doi.org\/10.1016\/j.clineuro.2006.09.001.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"2919_CR104","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/01.ta.0000250497.08101.8b","volume":"62","author":"EA Gonzalez","year":"2007","unstructured":"Gonzalez EA, Moore FA, Holcomb JB, Miller CC, Kozar RA, Todd SR, et al. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma. 2007;62(1):112\u20139. https:\/\/doi.org\/10.1097\/01.ta.0000250497.08101.8b.","journal-title":"J Trauma."},{"key":"2919_CR105","doi-asserted-by":"publisher","unstructured":"Henry DA, Carless PA, Moxey AJ, O\u2019Connell D, Stokes BJ, McClelland B et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2007;(4):Cd001886. https:\/\/doi.org\/10.1002\/14651858.CD001886.pub2","DOI":"10.1002\/14651858.CD001886.pub2"},{"issue":"3","key":"2919_CR106","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/SLA.0b013e318185a9ad","volume":"248","author":"JB Holcomb","year":"2008","unstructured":"Holcomb JB, Wade CE, Michalek JE, Chisholm GB, Zarzabal LA, Schreiber MA, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008;248(3):447\u201358. https:\/\/doi.org\/10.1097\/SLA.0b013e318185a9ad.","journal-title":"Ann Surg"},{"issue":"1","key":"2919_CR107","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/SLA.0b013e318176c4ec","volume":"248","author":"CC Hsia","year":"2008","unstructured":"Hsia CC, Chin-Yee IH, McAlister VC. Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials. Ann Surg. 2008;248(1):61\u20138. https:\/\/doi.org\/10.1097\/SLA.0b013e318176c4ec.","journal-title":"Ann Surg"},{"issue":"2","key":"2919_CR108","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/TA.0b013e31817de3e1","volume":"65","author":"JL Kashuk","year":"2008","unstructured":"Kashuk JL, Moore EE, Johnson JL, Haenel J, Wilson M, Moore JB, et al. Postinjury life threatening coagulopathy: is 1:1 fresh frozen plasma:packed red blood cells the answer? J Trauma. 2008;65(2):261\u201370. https:\/\/doi.org\/10.1097\/TA.0b013e31817de3e1. discussion 70\u2013\u20091.","journal-title":"J Trauma"},{"issue":"2","key":"2919_CR109","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/ALN.0b013e318194b21e","volume":"110","author":"WC Korte","year":"2009","unstructured":"Korte WC, Szadkowski C, G\u00e4hler A, Gabi K, Kownacki E, Eder M, et al. Factor XIII substitution in surgical cancer patients at high risk for intraoperative bleeding. Anesthesiology. 2009;110(2):239\u201345. https:\/\/doi.org\/10.1097\/ALN.0b013e318194b21e.","journal-title":"Anesthesiology"},{"key":"2919_CR110","doi-asserted-by":"publisher","unstructured":"Kwan I, Bunn F, Roberts I. Timing and volume of fluid administration for patients with bleeding. Cochrane Database Syst Rev. 2003;3Cd002245. https:\/\/doi.org\/10.1002\/14651858.Cd002245.","DOI":"10.1002\/14651858.Cd002245"},{"issue":"1","key":"2919_CR111","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.TA.0000075338.21177.EF","volume":"55","author":"JB MacLeod","year":"2003","unstructured":"MacLeod JB, Lynn M, McKenney MG, Cohn SM, Murtha M. Early coagulopathy predicts mortality in trauma. J Trauma. 2003;55(1):39\u201344.","journal-title":"J Trauma"},{"issue":"2","key":"2919_CR112","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1423-0410.2008.01074.x","volume":"95","author":"M Maegele","year":"2008","unstructured":"Maegele M, Lefering R, Paffrath T, Tjardes T, Simanski C, Bouillon B. Red-blood-cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiple injury: a retrospective analysis from the Trauma Registry of the Deutsche Gesellschaft f\u00fcr Unfallchirurgie. Vox Sang. 2008;95(2):112\u20139. https:\/\/doi.org\/10.1111\/j.1423-0410.2008.01074.x.","journal-title":"Vox Sang."},{"issue":"5","key":"2919_CR113","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1097\/01.Ta.0000060261.10597.5c","volume":"54","author":"DL Malone","year":"2003","unstructured":"Malone DL, Dunne J, Tracy JK, Putnam AT, Scalea TM, Napolitano LM. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma. 2003;54(5):898-905;discussion \u2013 7. https:\/\/doi.org\/10.1097\/01.Ta.0000060261.10597.5c.","journal-title":"J Trauma"},{"issue":"4","key":"2919_CR114","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1213\/01.ane.0000280481.18570.27","volume":"105","author":"M Mittermayr","year":"2007","unstructured":"Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Klingler A, et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg. 2007;105(4):905\u201317. https:\/\/doi.org\/10.1213\/01.ane.0000280481.18570.27.","journal-title":"Anesth Analg"},{"issue":"2","key":"2919_CR115","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/TA.0b013e3181961c35","volume":"66","author":"TC Nunez","year":"2009","unstructured":"Nunez TC, Voskresensky IV, Dossett LA, Shinall R, Dutton WD, Cotton BA. Early prediction of massive transfusion in trauma: simple as ABC (assessment of blood consumption)? J Trauma. 2009;66(2):346\u201352. https:\/\/doi.org\/10.1097\/TA.0b013e3181961c35.","journal-title":"J Trauma"},{"issue":"4","key":"2919_CR116","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/SLA.0b013e31818990","volume":"248","author":"TM Scalea","year":"2008","unstructured":"Scalea TM, Bochicchio KM, Lumpkins K, Hess JR, Dutton R, Pyle A, et al. Early aggressive use of fresh frozen plasma does not improve outcome in critically injured trauma patients. Ann Surg. 2008;248(4):578\u201384. https:\/\/doi.org\/10.1097\/SLA.0b013e31818990.","journal-title":"Ann Surg"},{"issue":"2","key":"2919_CR117","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/TA.0b013e318196c3ac","volume":"66","author":"CW Snyder","year":"2009","unstructured":"Snyder CW, Weinberg JA, McGwin G Jr, Melton SM, George RL, Reiff DA, et al. The relationship of blood product ratio to mortality: survival benefit or survival bias? J Trauma. 2009;66(2):358-62;discussion 62-4. https:\/\/doi.org\/10.1097\/TA.0b013e318196c3ac.","journal-title":"J Trauma"},{"issue":"5","key":"2919_CR118","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1097\/TA.0b013e3181878028","volume":"65","author":"JL Sperry","year":"2008","unstructured":"Sperry JL, Ochoa JB, Gunn SR, Alarcon LH, Minei JP, Cuschieri J, et al. An FFP:PRBC transfusion ratio >\/=1:1.5 is associated with a lower risk of mortality after massive transfusion. J Trauma. 2008;65(5):986\u201393. https:\/\/doi.org\/10.1097\/TA.0b013e3181878028.","journal-title":"J Trauma"},{"key":"2919_CR119","doi-asserted-by":"publisher","unstructured":"Stanworth SJ, Birchall J, Doree CJ, Hyde C. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev. 2007;(2):Cd005011\u00a0https:\/\/doi.org\/10.1002\/14651858.CD005011.pub2","DOI":"10.1002\/14651858.CD005011.pub2"},{"issue":"1","key":"2919_CR120","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1365-2141.2004.04973","volume":"126","author":"SJ Stanworth","year":"2004","unstructured":"Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DB, Murphy MF. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol. 2004;126(1):139\u201352. https:\/\/doi.org\/10.1111\/j.1365-2141.2004.04973.","journal-title":"Br J Haematol"},{"issue":"3","key":"2919_CR121","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/TA.0b013e31817e5c77","volume":"66","author":"PG Teixeira","year":"2009","unstructured":"Teixeira PG, Inaba K, Shulman I, Salim A, Demetriades D, Brown C, et al. Impact of plasma transfusion in massively transfused trauma patients. J Trauma. 2009;66(3):693\u20137. https:\/\/doi.org\/10.1097\/TA.0b013e31817e5c77.","journal-title":"J Trauma"},{"issue":"31","key":"2919_CR122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta4310","volume":"4","author":"J Turner","year":"2000","unstructured":"Turner J, Nicholl J, Webber L, Cox H, Dixon S, Yates D. A randomised controlled trial of prehospital intravenous fluid replacement therapy in serious trauma. Health Technol Assess. 2000;4(31):1\u201357.","journal-title":"Health Technol Assess"},{"issue":"3","key":"2919_CR123","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1365-3148.2008.00854.x","volume":"18","author":"R Weinkove","year":"2008","unstructured":"Weinkove R, Rangarajan S. Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfus Med. 2008;18(3):151\u20137. https:\/\/doi.org\/10.1111\/j.1365-3148.2008.00854.x.","journal-title":"Transfus Med."},{"issue":"6","key":"2919_CR124","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1097\/01.ta.0000220386.84012.bf","volume":"60","author":"N Y\u00fccel","year":"2006","unstructured":"Y\u00fccel N, Lefering R, Maegele M, Vorweg M, Tjardes T, Ruchholtz S, et al. Trauma Associated Severe Hemorrhage (TASH)-Score: probability of mass transfusion as surrogate for life threatening hemorrhage after multiple trauma. J Trauma. 2006;60(6):1228-36;discussion 36-7. https:\/\/doi.org\/10.1097\/01.ta.0000220386.84012.bf.","journal-title":"J Trauma"},{"issue":"5","key":"2919_CR125","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.amjsurg.2008.12.014","volume":"197","author":"KA Zink","year":"2009","unstructured":"Zink KA, Sambasivan CN, Holcomb JB, Chisholm G, Schreiber MA. A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study. Am J Surg. 2009;197(5):565\u201370. https:\/\/doi.org\/10.1016\/j.amjsurg.2008.12.014. discussion 70.","journal-title":"Am J Surg"},{"key":"2919_CR126","doi-asserted-by":"crossref","first-page":"A53","DOI":"10.1055\/s-0037-1617203","volume":"29","author":"RBAF Zotz","year":"2009","unstructured":"Zotz RBAF, Bux I. Desmopressin (DDAVP) for minimising perioperative allogenic blood transfusion: a stratified metaanalysis. Hamostaseologie. 2009;29:A53.","journal-title":"Hamostaseologie"},{"issue":"1","key":"2919_CR127","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/bjh.14255","volume":"175","author":"K Kolev","year":"2016","unstructured":"Kolev K, Longstaff C. Bleeding related to disturbed fibrinolysis. Br J Haematol. 2016;175(1):12\u201323. https:\/\/doi.org\/10.1111\/bjh.14255.","journal-title":"Br J Haematol"},{"issue":"12","key":"2919_CR128","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1016\/j.injury.2018.09.033","volume":"49","author":"ER Lusczek","year":"2018","unstructured":"Lusczek ER, Myers C, Popovsky K, Mulier K, Beilman G, Sawyer R. Plasma metabolomics pilot study suggests age and sex-based differences in the metabolic response to traumatic injury. Injury. 2018;49(12):2178\u201385. https:\/\/doi.org\/10.1016\/j.injury.2018.09.033.","journal-title":"Injury"},{"issue":"6","key":"2919_CR129","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/TA.0000000000000341","volume":"77","author":"HB Moore","year":"2014","unstructured":"Moore HB, Moore EE, Gonzalez E, Chapman MP, Chin TL, Silliman CC, et al. Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy. J Trauma Acute Care Surg. 2014;77(6):811\u20137.","journal-title":"J Trauma Acute Care Surg"},{"issue":"3","key":"2919_CR130","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1213\/ANE.0000000000004234","volume":"129","author":"HB Moore","year":"2019","unstructured":"Moore HB, Moore EE, Neal MD, Sheppard FR, Kornblith LZ, Draxler DF, et al. Fibrinolysis shutdown in trauma: historical review and clinical implications. Anesth Analg. 2019;129(3):762\u201373. https:\/\/doi.org\/10.1213\/ANE.0000000000004234.","journal-title":"Anesth Analg"},{"issue":"6","key":"2919_CR131","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1097\/ta.0000000000001718\/2pmc5726780\/m29190254","volume":"83","author":"HB Moore","year":"2017","unstructured":"Moore HB, Moore EE, Huebner BR, Dzieciatkowska M, Stettler GR, Nunns GR, et al. Fibrinolysis shutdown is associated with a fivefold increase in mortality in trauma patients lacking hypersensitivity to tissue plasminogen activator. J Trauma Acute Care Surg. 2017;83(6):1014\u201322. https:\/\/doi.org\/10.1097\/ta.0000000000001718\/2pmc5726780\/m29190254.","journal-title":"J Trauma Acute Care Surg"},{"issue":"3","key":"2919_CR132","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/TA.0000000000001792","volume":"84","author":"JP Meizoso","year":"2018","unstructured":"Meizoso JP, Dudaryk R, Mulder MB, Ray JJ, Karcutskie CA, Eidelson SA, et al. Increased risk of fibrinolysis shutdown among severely injured trauma patients receiving Tranexamic acid. J Trauma Acute Care Surg. 2018;84(3):426\u201332. https:\/\/doi.org\/10.1097\/TA.0000000000001792.","journal-title":"J Trauma Acute Care Surg"},{"key":"2919_CR133","doi-asserted-by":"crossref","first-page":"8071619","DOI":"10.1155\/2019\/8071619","volume":"2019","author":"V Bogner-Flatz","year":"2019","unstructured":"Bogner-Flatz V, Braunstein M, Ocker LE, Kusmenkov T, Tschoep J, Ney L, et al. On-the-Scene Hyaluronan and Syndecan-1 Serum Concentrations and Outcome after Cardiac Arrest and Resuscitation. Mediators Inflamm. 2019;2019:8071619.","journal-title":"Mediators Inflamm"},{"issue":"2","key":"2919_CR134","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/TA.0000000000002099","volume":"86","author":"DJ Roberts","year":"2019","unstructured":"Roberts DJ, Kalkwarf KJ, Moore HB, Cohen MJ, Fox EE, Wade CE, et al. Time course and outcomes associated with transient versus persistent fibrinolytic phenotypes after injury: A nested, prospective, multicenter cohort study. J Trauma Acute Care Surg. 2019;86(2):206\u201313. https:\/\/doi.org\/10.1097\/TA.0000000000002099.","journal-title":"J Trauma Acute Care Surg"},{"key":"2919_CR135","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ajem.2020.12.065","volume":"41","author":"JP Wray","year":"2021","unstructured":"Wray JP, Bridwell RE, Schauer SG, Shackelford SA, Bebarta VS, Wright FL, et al. The diamond of death: hypocalcemia in trauma and resuscitation. Am J Emerg Med. 2021;41:104\u20139. https:\/\/doi.org\/10.1016\/j.ajem.2020.12.065.","journal-title":"Am J Emerg Med"},{"key":"2919_CR136","first-page":"6","volume":"28","author":"C Fenger-Eriksen","year":"2019","unstructured":"Fenger-Eriksen C, Haas T, Fries D. Coagulation disturbances during major perioperative or traumatic bleeding. Trends Anaesth Crit Care. 2019;28:6\u201313.","journal-title":"Trends Anaesth Crit Care"},{"issue":"3","key":"2919_CR137","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00101-018-0411-z","volume":"67","author":"H Lier","year":"2018","unstructured":"Lier H, Bernhard M, Hossfeld B. Hypovol\u00e4misch-h\u00e4morrhagischer Schock. Anaesthesist. 2018;67(3):225\u201344. https:\/\/doi.org\/10.1007\/s00101-018-0411-z.","journal-title":"Anaesthesist."},{"issue":"1","key":"2919_CR138","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/SHK.0000000000001866","volume":"57","author":"HR Kregel","year":"2022","unstructured":"Kregel HR, Hatton GE, Isbell KD, Henriksen HH, Stensballe J, Johansson PI, et al. Shock-Induced endothelial dysfunction is present in patients with occult hypoperfusion after trauma. Shock. 2022;57(1):106\u201312. https:\/\/doi.org\/10.1097\/SHK.0000000000001866.","journal-title":"Shock"},{"issue":"8","key":"2919_CR139","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/emermed-2015-205096","volume":"33","author":"S Webster","year":"2016","unstructured":"Webster S, Todd S, Redhead J, Wright C. Ionised calcium levels in major trauma patients who received blood in the emergency department. Emerg Med J. 2016;33(8):569\u201372. https:\/\/doi.org\/10.1136\/emermed-2015-205096.","journal-title":"Emerg Med J"},{"issue":"6","key":"2919_CR140","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2450\/2020.0065-20","volume":"18","author":"R Consunji","year":"2020","unstructured":"Consunji R, Elseed A, El-Menyar A, Sathian B, Rizoli S, Al-Thani H, et al. The effect of massive transfusion protocol implementation on the survival of trauma patients: a systematic review and meta-analysis. Blood Transfus. 2020;18(6):434\u201345. https:\/\/doi.org\/10.2450\/2020.0065-20.","journal-title":"Blood Transfus"},{"key":"2919_CR141","unstructured":"Bundes\u00e4rztekammer (B\u00c4K). Querschnitts-Leitlinien (B\u00c4K) zur Therapie mit Blutkomponenten und Plasmaderivaten \u2013 Gesamtnovelle 2020 2020 [cited 2021 10 Jan 2021]. Available from: https:\/\/www.bundesaerztekammer.de\/aerzte\/medizin-ethik\/wissenschaftlicher-beirat\/veroeffentlichungen\/haemotherapietransfusionsmedizin\/querschnitt-leitlinie\/"},{"key":"2919_CR142","doi-asserted-by":"publisher","unstructured":"Sperry JL, Guyette FX, Brown JB, Yazer MH, Triulzi DJ, Early-Young BJ et al. Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock. N Engl J Med. 2018;379(4):315\u2013\u200926%7 2018\/07\/26%8 Jul 26%! Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock %@ 1533\u20134406 (Electronic) 0028-4793 (Linking). https:\/\/doi.org\/10.1056\/NEJMoa1802345\/M 30044935.","DOI":"10.1056\/NEJMoa1802345\/M"},{"issue":"10144","key":"2919_CR143","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(18)31553-8","volume":"392","author":"HB Moore","year":"2018","unstructured":"Moore HB, Moore EE, Chapman MP, McVaney K, Bryskiewicz G, Blechar R, et al. Plasma-first resuscitation to treat haemorrhagic shock during emergency ground transportation in an urban area: a randomised trial. Lancet. 2018;392(10144):283\u201391. https:\/\/doi.org\/10.1016\/S0140-6736(18)31553-8.","journal-title":"Lancet"},{"issue":"1","key":"2919_CR144","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/rth2.12172","volume":"3","author":"M Makris","year":"2019","unstructured":"Makris M, Iorio A. Prehospital fresh frozen plasma: universal life saver or treatment in search of a target population? Res Pract Thromb Haemost. 2019;3(1):12\u20134. https:\/\/doi.org\/10.1002\/rth2.12172.","journal-title":"Res Pract Thromb Haemost"},{"issue":"4","key":"2919_CR145","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/TA.0000000000003323","volume":"91","author":"TWH Rijnhout","year":"2021","unstructured":"Rijnhout TWH, Duijst J, Noorman F, Zoodsma M, van Waes OJF, Verhofstad MHJ, et al. Platelet to erythrocyte transfusion ratio and mortality in massively transfused trauma patients. A systematic review and meta-analysis. J Trauma Acute Care Surg. 2021;91(4):759\u201371. https:\/\/doi.org\/10.1097\/TA.0000000000003323.","journal-title":"J Trauma Acute Care Surg"},{"key":"2919_CR146","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13054-015-0823-y","volume":"19","author":"JS Hagemo","year":"2015","unstructured":"Hagemo JS, Christiaans SC, Stanworth SJ, Brohi K, Johansson PI, Goslings JC, et al. Detection of acute traumatic coagulopathy and massive transfusion requirements by means of rotational thromboelastometry: an international prospective validation study. Crit Care. 2015;19:97. https:\/\/doi.org\/10.1186\/s13054-015-0823-y.","journal-title":"Crit Care"},{"issue":"7","key":"2919_CR147","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/anae.14670","volume":"74","author":"J Gratz","year":"2019","unstructured":"Gratz J, Guting H, Thorn S, Brazinova A, Gorlinger K, Schafer N, et al. Protocolised thromboelastometric-guided haemostatic management in patients with traumatic brain injury: a pilot study. Anaesthesia. 2019;74(7):883\u201390. https:\/\/doi.org\/10.1111\/anae.14670.","journal-title":"Anaesthesia"},{"issue":"6","key":"2919_CR148","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/SLA.0000000000002825","volume":"270","author":"K Baksaas-Aasen","year":"2019","unstructured":"Baksaas-Aasen K, Van Dieren S, Balvers K, Juffermans NP, Naess PA, Rourke C, et al. Data-driven development of ROTEM and TEG algorithms for the management of trauma hemorrhage: A prospective observational multicenter study. Ann Surg. 2019;270(6):1178\u201385.","journal-title":"Ann Surg"},{"issue":"12","key":"2919_CR149","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1097\/CCM.0b013e3182281af5","volume":"39","author":"R Davenport","year":"2011","unstructured":"Davenport R, Manson J, De\u2019Ath H, Platton S, Coates A, Allard S, et al. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med. 2011;39(12):2652\u20138. https:\/\/doi.org\/10.1097\/CCM.0b013e3182281af5.","journal-title":"Crit Care Med"},{"issue":"9","key":"2919_CR150","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/anae.14297","volume":"73","author":"JM Kelly","year":"2018","unstructured":"Kelly JM, Rizoli S, Veigas P, Hollands S, Min A. Using rotational thromboelastometry clot firmness at 5 minutes (ROTEM((R)) EXTEM A5) to predict massive transfusion and in-hospital mortality in trauma: a retrospective analysis of 1146 patients. Anaesthesia. 2018;73(9):1103\u20139. https:\/\/doi.org\/10.1111\/anae.14297.","journal-title":"Anaesthesia"},{"issue":"6","key":"2919_CR151","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1097\/TA.0000000000002944","volume":"89","author":"N Bugaev","year":"2020","unstructured":"Bugaev N, Como JJ, Golani G, Freeman JJ, Sawhney JS, Vatsaas CJ, et al. Thromboelastography and rotational thromboelastometry in bleeding patients with coagulopathy: practice management guideline from the Eastern association for the surgery of trauma. J Trauma Acute Care Surg. 2020;89(6):999\u20131017. https:\/\/doi.org\/10.1097\/TA.0000000000002944.","journal-title":"J Trauma Acute Care Surg"},{"issue":"7","key":"2919_CR152","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/17512433.2020.1776608","volume":"13","author":"SR Leal-Noval","year":"2020","unstructured":"Leal-Noval SR, Fernandez Pacheco J, Casado Mendez M, Cuenca-Apolo D, Munoz-Gomez M. Current perspective on fibrinogen concentrate in critical bleeding. Expert Rev Clin Pharmacol. 2020;13(7):761\u201378.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"2","key":"2919_CR153","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/SHK.0000000000001622","volume":"55","author":"AT Fields","year":"2021","unstructured":"Fields AT, Matthay ZA, Nunez-Garcia B, Matthay EC, Bainton RJ, Callcut RA, et al. Good platelets gone bad: the effects of trauma patient plasma on healthy platelet aggregation. Shock. 2021;55(2):189\u201397. https:\/\/doi.org\/10.1097\/SHK.0000000000001622.","journal-title":"Shock"},{"issue":"1","key":"2919_CR154","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13054-019-2347-3","volume":"23","author":"DR Spahn","year":"2019","unstructured":"Spahn DR, Bouillon B, Cerny V, Duranteau J, Filipescu D, Hunt BJ, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit Care. 2019;23(1):98. https:\/\/doi.org\/10.1186\/s13054-019-2347-3.","journal-title":"Crit Care"},{"issue":"3","key":"2919_CR155","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.transci.2010.09.002","volume":"43","author":"PI Johansson","year":"2010","unstructured":"Johansson PI. Goal-directed hemostatic resuscitation for massively bleeding patients: the Copenhagen concept. Transfus Apher Sci. 2010;43(3):401\u20135.","journal-title":"Transfus Apher Sci"},{"issue":"9734","key":"2919_CR156","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","volume":"376","author":"H CRASH-trial collaborators, Shakur","year":"2010","unstructured":"CRASH-trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, et al. Effects of Tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23\u201332.","journal-title":"Lancet"},{"key":"2919_CR157","doi-asserted-by":"publisher","unstructured":"Al-Jeabory M, Szarpak L, Attila K, Simpson M, Smereka A, Gasecka A, et al. Efficacy and Safety of Tranexamic Acid in Emergency Trauma: A Systematic Review and Meta-Analysis. J Clin Med. 2021;10(5). https:\/\/doi.org\/10.3390\/jcm10051030.","DOI":"10.3390\/jcm10051030"},{"issue":"10","key":"2919_CR158","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jama.2020.8958","volume":"324","author":"SE Rowell","year":"2020","unstructured":"Rowell SE, Meier EN, McKnight B, Kannas D, May S, Sheehan K, et al. Effect of Out-of-Hospital Tranexamic acid vs placebo on 6-Month functional neurologic outcomes in patients with moderate or severe traumatic brain injury. JAMA. 2020;324(10):961\u201374. https:\/\/doi.org\/10.1001\/jama.2020.8958.","journal-title":"JAMA"},{"issue":"12","key":"2919_CR159","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/S1474-4422(20)30369-0","volume":"19","author":"A Meretoja","year":"2020","unstructured":"Meretoja A, Yassi N, Wu TY, Churilov L, Sibolt G, Jeng JS, et al. Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2020;19(12):980\u20137. https:\/\/doi.org\/10.1016\/S1474-4422(20)30369-0.","journal-title":"Lancet Neurol"},{"issue":"3","key":"2919_CR160","doi-asserted-by":"publisher","first-page":"e605","DOI":"10.1097\/SLA.0000000000004548","volume":"275","author":"NG Vigneshwar","year":"2022","unstructured":"Vigneshwar NG, Moore EE, Moore HB, Cotton BA, Holcomb JB, Cohen MJ, et al. Precision medicine: clinical tolerance to hyperfibrinolysis differs by shock and injury severity. Ann Surg. 2022;275(3):e605-7. https:\/\/doi.org\/10.1097\/SLA.0000000000004548.","journal-title":"Ann Surg"},{"issue":"1","key":"2919_CR161","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/ALN.0000000000004036","volume":"136","author":"A Rossetto","year":"2022","unstructured":"Rossetto A, Vulliamy P, Lee KM, Brohi K, Davenport R. Temporal transitions in fibrinolysis after trauma: adverse outcome is principally related to late hypofibrinolysis. Anesthesiology. 2022;136(1):148\u201361. https:\/\/doi.org\/10.1097\/ALN.0000000000004036.","journal-title":"Anesthesiology"},{"issue":"3","key":"2919_CR162","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/jth.14378","volume":"17","author":"NP Juffermans","year":"2019","unstructured":"Juffermans NP, Wirtz MR, Balvers K, Baksaas-Aasen K, van Dieren S, Gaarder C, et al. Towards patient-specific management of trauma hemorrhage: the effect of resuscitation therapy on parameters of thromboelastometry. J Thromb Haemost. 2019;17(3):441\u20138. https:\/\/doi.org\/10.1111\/jth.14378.","journal-title":"J Thromb Haemost"},{"key":"2919_CR163","doi-asserted-by":"publisher","unstructured":"Innerhofer N, Treichl B, Rugg C, Fries D, Mittermayr M, Hell T et al. First-Line Administration of Fibrinogen Concentrate in the Bleeding Trauma Patient: Searching for Effective Dosages and Optimal Post-Treatment Levels Limiting Massive Transfusion-Further Results of the RETIC Study. J Clin Med. 2021;10(17).\u00a0https:\/\/doi.org\/10.3390\/jcm10173930.","DOI":"10.3390\/jcm10173930"},{"key":"2919_CR164","doi-asserted-by":"publisher","unstructured":"Cerny V, Maegele M, Agostini V, Fries D, Leal-Noval SR, Nardai G et al. Variations and obstacles in the use of coagulation factor concentrates for major trauma bleeding across Europe: outcomes from a European expert meeting. Eur J Trauma Emerg Surg. 2021. https:\/\/doi.org\/10.1007\/s00068-020-01563-2.","DOI":"10.1007\/s00068-020-01563-2"},{"key":"2919_CR165","doi-asserted-by":"publisher","unstructured":"Gratz J, Schlimp CJ, Honickel M, Hochhausen N, Schochl H, Grottke O. Sufficient Thrombin Generation Despite 95% Hemodilution: An In Vitro Experimental Study. J Clin Med. 2020;9(12). https:\/\/doi.org\/10.3390\/jcm9123805.","DOI":"10.3390\/jcm9123805"},{"issue":"5","key":"2919_CR166","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jamcollsurg.2020.12.058","volume":"232","author":"JR Coleman","year":"2021","unstructured":"Coleman JR, Moore EE, Samuels JM, Cohen MJ, Silliman CC, Ghasabyan A, et al. Whole blood thrombin generation in severely injured patients requiring massive transfusion. J Am Coll Surg. 2021;232(5):709\u201316. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2020.12.058.","journal-title":"J Am Coll Surg"},{"issue":"10","key":"2919_CR167","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1111\/jth.14991","volume":"18","author":"DP van den Brink","year":"2020","unstructured":"van den Brink DP, Wirtz MR, Neto AS, Schochl H, Viersen V, Binnekade J, et al. Effectiveness of prothrombin complex concentrate for the treatment of bleeding: A systematic review and meta-analysis. J Thromb Haemost. 2020;18(10):2457\u201367. https:\/\/doi.org\/10.1111\/jth.14991.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2919_CR168","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1378\/chest.11-1444","volume":"140","author":"KM Ho","year":"2011","unstructured":"Ho KM, Chavan S, Pilcher D. Omission of early thromboprophylaxis and mortality in critically ill patients: a multicenter registry study. Chest. 2011;140(6):1436\u201346. https:\/\/doi.org\/10.1378\/chest.11-1444.","journal-title":"Chest"}],"container-title":["European Journal of Trauma and Emergency Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00068-025-02919-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00068-025-02919-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00068-025-02919-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T21:02:20Z","timestamp":1770757340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00068-025-02919-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":168,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2919"],"URL":"https:\/\/doi.org\/10.1007\/s00068-025-02919-2","relation":{},"ISSN":["1863-9933","1863-9941"],"issn-type":[{"value":"1863-9933","type":"print"},{"value":"1863-9941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required, because the study used publicly accessible documents as evidence.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"Heiko Lier declares that he has received honoraria for lectures and travel fees from AstraZeneca, Bayer Vital, DRK-Blutspendedienst West, CSL Behring, Ferring, Mitsubishi Pharma, NovoNordisk, Organon, and Werfen. Marc Maegele declares that he has received honoraria for lectures, participation in expert\/advisory board committees and financial support for participation in congresses and scientific projects from Abbott, Astra Zeneca, Baxter, Bayer, Biotest, CSL Behring, IL-Werfen\/TEM-International, LFB, Biomedicaments France, Portola, and Octapharma. K\u00e4the Goossen, Charlotte M. Kugler, Erwin Strasser, Bjoern Hussmann, and Peter Hilbert\u2010Carius declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"240"}}